SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG
0
Add to list
GB COVID-19 Ag POCT
Cat. No. 4ECO101E
More details>
(3 items)
SOLUTIONS PRODUCTS INNOVATION INVESTORS ESG About GBC Our Brands R&D Media Join us Contact us
English 繁體中文
IVD Solutions
Menu
ANTICORASE MB-96 (TMB) (Anti-HBc IgM)
High-sensitivity IgM capture ELISA for detection of Anti-HBc IgM, hallmark of acute HBV core antigen infection. Specificity 100%, sample only 5 µL, TFDA & CE certified.
USEFUL RESOURCES
Add to List
>  PRODUCT DESCRIPTION>  SPECIFICATION>  PERFORMANCE>  ORDERING INFORMATION
PRODUCT DESCRIPTION
This product is an IgM capture ELISA assay for qualitative detection of Anti-HBc IgM in human serum or plasma, indicative of acute hepatitis B virus (HBV) infection. It requires only 5 µL sample volume, with a 150-minute incubation and 450 nm read wavelength. Tested in 1,541 hospitalized patients, showing 96.1% sensitivity and 100% specificity. Certified by TFDA and CE; storage at 2-8°C.
SPECIFICATION
Number of wells96
PrincipleIgM Capture
Assay formatQualitative
Total incubation time150 minutes
Sample typeSerum / Plasma
Sample volume5 μL
Reading wavelength450nm
Storage2-8°C
CertificationTFDA / CE marked ✱

✱Notified body: 0344

PERFORMANCE

1541 hospitalized patients were tested. The results are as follows:

PERFORMANCETest PositiveTest Negative
Confirmed Positive5511
Confirmed Negative5984
Inter-assay precision CV< 25%Intra-assay precision CV< 20%

The diagnostic sensitivity is 96.1%;The diagnostic specificity is 100%

ORDERING INFORMATION
Catalogue No.Product
4CME3ANTICORASE MB-96 (TMB)